Acomplia Likely to be Faced with Competition from Merck and Pfizer Weight Loss Products

PRLog (Press Release) – Aug 02, 2007 – Acomplia, a Sanofi-Aventis creation has been in news ever since its launch in 2006. Its efficacy is established by the long trail of its users in several European and Latin-American countries. But it might have to face competition from some new weight loss products which are currently in the pipeline.      

Senior marketing executive at Weight Loss Drug Mr. Samuel Venture comments, “With the growing popularity of Acomplia, several drug- makers have sprung up with new weight loss formulations, which are likely to give competition to the Sanofi-Aventis creation. At present, Acomplia has a strong contender which may challenge its position. Taranabant developed by Merck, which is undergoing its Phase III”

Mr. Venture further comments, “Besides Merck, drug-maker Pfizer too is not behind in the race to develop competitor to the   weight loss medication Acomplia(http://www.weight-loss-drug.co.uk/rimonabant_acomplia.html). CP-945598, a Pfizer product is also under Phase III stage, preparing to give a competition to Acomplia”.

Both of these up coming weight loss medications act on the similar principle as Acomplia diet drug. This is to imply that both of these medications affect the Cannabinoid system, curb the excessive appetite and thereby source weight loss. But the fate of the medications is yet to ascertained, which is possible only after their launch in the market.  

Weight Loss Drug(http://www.weight-loss-drug.co.uk) is an informative website, which provides information on weight loss medication such as Acomplia, Xenical, Phentermine, Bontril, Didrex, Phendimetrazine, Reductil, Ionamin, Hoodia diet pill, Alli, Pramlintide, and Lorcaserin amid others to enhance your scope of information. Reasons for weight gain, how to lose weight, diet pills information are other group of information made available at Weight Loss Drug. Latest news, articles, BMI calculator are some of the other beneficial features made accessible at Weight Loss Drug.

For getting access to more information pertaining to Acomplia, visit at http://www.weight-loss-drug.co.uk/rimonabant_acomplia.html